Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02867956
Recruitment Status : Active, not recruiting
First Posted : August 16, 2016
Last Update Posted : June 26, 2019
Sponsor:
Information provided by (Responsible Party):
Xin Huang, Sun Yat-sen University